GCAC Announces wellness Canada health Cannabis product sales permit

Vancouver, British Columbia, Canada – TheNewswire – February 4, 2021 – Global Cannabis Applications Corp. (” GCAC” or the ” business” ) (CNSX:APP.CN) (FSE:2FA) (OTC:FUAPF), a respected medical cannabis chain-of-custody conformity and information platform, today announced this has commenced the certification procedure to be a wellness Canada health product sales License owner underneath the Cannabis Act. GCAC will run as a non-possession cannabis store that connects purchasers to cultivators via wellness Canada professionals making use of a dropship that is retail.

GCAC developed a cannabis-Consultation that is new for Efixii, where clients request an in-app assessment for medical cannabis with a registered wellness Canada practitioner. Then, prior to the Cannabis Act, the practitioner makes the patient’s official Medical Document and delivers to your GCAC store where in fact the client purchases efixii-certified cannabis that are medical

GCAC’s recent funding of $1 million dollars will be used to acquire a Medical Sales License and establish a dropship web shop that is retail. GCAC’s agreement that is prior Purity-IQ means that the Efixii shop dropships trustworthy, certified medical cannabis, thereby ensuring better patient outcomes.

Canada is the world’s largest federally regulated market for medical cannabis, with $600 million in medical cannabis sales per year [1]. However, only 37% of canadians cannabis that are using medical purposes have actually a Health Canada health Document from a health-care practitioner [2]. Efixii modifications that by simply making health papers more straightforward to obtain, through the comfortable surroundings of your own home, and also by additionally providing the quality that is highest, Efixii-certified medical cannabis direct to patients.

Brad Moore, CEO of GCAC said, “We know that Efixii ensures transparency from seed to sale but we’re acutely aware of both the lack of trust and difficulty in acquiring consistent cannabis that are medical. That’s why we developed our proprietary health-care concept that is in-app. It combines Efixii-certified cultivators powered by Purity-IQ’s Cannabis Authenticity & Purity Standard (CAPS), which also requires brands to conduct batch-to-batch scientific and fingerprint that is proprietary, to provide the greatest, best and constant medical cannabis experience for all Canadians.”

“Our retail dropship platform provides a fresh revenue that is GCAC, as we will mark-up our wholesale cannabis pricing. And the Efixii health-care practitioner feature shall provide to operate a vehicle cultivators to look at, and SaaS permit, the Efixii-certified transparency standard.” proceeded Brad.

GCAC’s cannabis information is the property that is intellectual“IP”) of GCAC. The IP creates an difficulty that is inherent replicating, or straight contending with GCAC’s medical cannabis datasets. GCAC defined their protocols in a patent that is provisional, ‘System of Process and Tracking Cannabis Products and Associated Method Using Blockchain’ as filed with the U.S. Patent and Trademark Office on December 17, 2020.

[1] Https* that is://mjbizdaily.com/medical-cannabis-registrations-surge-in-canada-amid-pandemic/( https://mjbizdaily.com/access-barriers-stall-canadian-medical-cannabis-market/

About Worldwide Cannabis Applications Corp.

Global Cannabis Applications Corp. is a leader that is global designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world’s first that is end-to-end patient to regulator – medical cannabis information solutions. They normally use six main technologies: mobile applications, synthetic cleverness, RegTech, smart databases, Ethereum blockchain and GCAC smart benefits. These technologies transparently disclose cannabis events that are chain-of-custody thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring quality that is high datasets that improve patient results and also to get to be the world’s biggest cannabis effectiveness information provider.

For more business information, please visit http://www.cannappscorp.com , or review its pages on http://www.sedar.com as well as on the Canadian Securities Exchange‘s http://www.thecse.com that is website .

Press Contact

Phone: +1 (800) 409-5679

Email: [email protected]

Forward-Looking Information

This news release may include information that is forward-looking this is of Canadian securities legislation, in regards to the company of GCAC. Forward-looking information is dependant on specific expectations that are key assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such information that is forward-looking based are reasonable, undue reliance shouldn’t be positioned on the forward-looking information because GCAC will give no assurance that they can turn out to be proper. Forward-looking statements included in this news launch are built at the time of the date of the news launch. GCAC disclaims any intent or responsibility to upgrade publicly any information that is forward-looking whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this given information.

Copyright (c) 2021 TheNewswire – All legal rights reserved.

Get Real-Time Updates from MJobserver.com

Latest posts